Upcoming Events


June 25-27, 2018

Analytical Procedures and Methods Validation

Visit VTI Life Sciences in San Diego

June 25June 27

San Diego, United States

Choose from Over 20 Tutorials Addressing Today’s Top Analytical Challenges

FDA, ICH and USP all recognize Analytical Development and Validation as top priority in the drug development process and each have respective guidance, albeit interpretation is left to industry. Not only does this event take a deep dive into how companies comply with regulations, but also showcases how leading companies develop methods, validate procedures and generate data and information that lead to critical business decisions. This conference takes participants through a best practice journey through the development, validation and transfer of analytical methods

Click Here for More Information

 


June 25-27, 2018

Stability Testing and Program Management

Visit VTI Life Sciences in San Diego

June 25June 27

San Diego, United States

Stability Testing & Program Management Excellence

Stability testing is critical to the efficacy of drug substances. ICH, FDA and WHO stability guidance’s have been around for quite some time and are strictly enforced, however, industry still has challenges to overcome and seeks more direction. The time has never been more critical to evaluate your program  and ensure your organization has an advanced, compliant processes that exceed the expectations of regulators. . KENX is pleased to announce that our comprehensive Stability Testing & Program Management is headed to San Diego to showcase programs and procedures that excel and avoid regulatory action.

Click Here for More Information


June 25-27, 2018

Laboratory Data Integrity Compliance Congress

Visit VTI Life Sciences in San Diego

June 25June 27

San Diego, United States

Recent FDA Warning Letters Highlight Laboratory Data Integrity Deficiencies

FDA has issued many Warning Letters emphasizing data integrity non-compliance primarily in the  analytical environment. These serious findings include; having interrupted, missing, deleted and lost data; inadequate records for risk analysis; failure to exercise appropriate controls; failure to validate computer software; failure to establish validation procedures; manipulation and deletion of audit trails; and many more. The time has never been more critical to evaluate and ensure your organization has top-notch compliant procedures. KENX is pleased to announce that our comprehensive Laboratory Data Integrity Compliance Congress is headed to San Diego and showcases the protocols, methodology and actions necessary to avoid regulatory action.

Click Here for More Information